- Home
- SMHI vs FENC Comparison
SMHI vs FENC Comparison
Compare SMHI & FENC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- SMHI
- FENC
- Stock Information
- Founded
- SMHI 1989
- FENC 1996
- Country
- SMHI United States
- FENC United States
- Employees
- SMHI N/A
- FENC N/A
- Industry
- SMHI Marine Transportation
- FENC Biotechnology: Biological Products (No Diagnostic Substances)
- Sector
- SMHI Consumer Discretionary
- FENC Health Care
- Exchange
- SMHI Nasdaq
- FENC Nasdaq
- Market Cap
- SMHI 142.2M
- FENC 156.9M
- IPO Year
- SMHI N/A
- FENC 2001
- Fundamental
- Price
- SMHI $5.34
- FENC $8.12
- Analyst Decision
- SMHI
- FENC Strong Buy
- Analyst Count
- SMHI 0
- FENC 2
- Target Price
- SMHI N/A
- FENC $13.00
- AVG Volume (30 Days)
- SMHI 98.1K
- FENC 105.2K
- Earning Date
- SMHI 04-30-2025
- FENC 05-13-2025
- Dividend Yield
- SMHI N/A
- FENC N/A
- EPS Growth
- SMHI N/A
- FENC N/A
- EPS
- SMHI N/A
- FENC N/A
- Revenue
- SMHI $264,089,999.00
- FENC $30,912,000.00
- Revenue This Year
- SMHI $4.13
- FENC N/A
- Revenue Next Year
- SMHI $8.55
- FENC $58.65
- P/E Ratio
- SMHI N/A
- FENC N/A
- Revenue Growth
- SMHI N/A
- FENC N/A
- 52 Week Low
- SMHI $3.63
- FENC $3.96
- 52 Week High
- SMHI $15.36
- FENC $8.56
- Technical
- Relative Strength Index (RSI)
- SMHI 57.17
- FENC 71.48
- Support Level
- SMHI $4.84
- FENC $7.56
- Resistance Level
- SMHI $5.54
- FENC $8.34
- Average True Range (ATR)
- SMHI 0.25
- FENC 0.47
- MACD
- SMHI 0.04
- FENC 0.10
- Stochastic Oscillator
- SMHI 71.43
- FENC 83.27
About SMHI SEACOR Marine Holdings Inc.
Seacor Marine Holdings Inc provides marine and support transportation services to offshore energy facilities globally. The company operates and manages a diverse fleet of offshore support vessels that deliver cargo and personnel to offshore installations, including wind farms, handle anchors, and mooring equipment for offshore rigs and platforms. Its geographical segment includes the United States (Gulf of Mexico), Africa and Europe, Middle East and Asia, and Latin America.
About FENC Fennec Pharmaceuticals Inc.
Fennec Pharmaceuticals Inc is a commercial-stage biopharmaceutical company. Its product candidate is PEDMARK which is sodium thiosulfate in a novel formulation for the prevention of cisplatin-induced hearing loss, or ototoxicity in children. The company principally operates in the United States.